Answer:
Liz, received the two primary doses of MCV4, now she will have to receive one more dose every 5 years.
Explanation:
HIV-infected patients have a lower immunogenicity response than that obtained by the general population with routine immunization. The meningococcal C conjugate vaccine, also called MCV4, is indicated for this population infected with the HIV virus. The recommendation of this vaccine for adults infected with this virus is that the vaccine should be offered in 2 doses, 2 months apart, and a new booster every 5 years.
The purpose of this vaccine is to increase client immunity.
